CHI HEALTH SCHUYLER — Hospital Ledger

45 CFR § 180 compliance

A · 100

This hospital published most of what § 180 requires.

●Machine-readable file published

●Gross / standard charges

●Discounted cash price

●Payer-specific negotiated rates

●Min / max negotiated charges

●Free, public, no login required

Procedures listed

11,018

Insurances with rates

CPT / HCPCS codes

7,422

Source MRF

json ↗

Most expensive procedures (gross)

Code	Description	Gross	Cash	Min payer	Max payer	# insurers
J0225	VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE	$596,755	$507,242	$538,571	$584,820	19
J0225	VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE	$596,755	$507,242	$127,825	$675,646	32
A9513	LUTETIUM LU 177 DOTATATE 10 MCI/ML (370 MBQ/ML) INTRAVENOUS SOLUTION	$237,500	$201,875	$214,344	$232,750	19
A9513	LUTETIUM LU 177 DOTATATE 10 MCI/ML (370 MBQ/ML) INTRAVENOUS SOLUTION	$237,500	$201,875	$50,873	$268,898	32
J1823	INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION	$218,333	$185,583	$197,046	$213,966	19
J1823	INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION	$218,333	$185,583	$46,767	$247,197	32
J2351	OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23000 UNIT/23 ML SUBCUT SOLN	$206,410	$175,448	$186,285	$202,281	19
J2351	OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23000 UNIT/23 ML SUBCUT SOLN	$206,410	$175,448	$44,213	$233,697	32
C9293	GLUCARPIDASE 1000 UNIT INTRAVENOUS SOLUTION	$205,870	$174,990	$185,798	$201,753	19
C9293	GLUCARPIDASE 1000 UNIT INTRAVENOUS SOLUTION	$205,870	$174,990	$44,097	$233,086	32
J9228	IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION	$177,544	$150,912	$160,233	$173,993	19
J9228	IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION	$177,544	$150,912	$38,030	$201,015	32
J1747	SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION	$127,833	$108,658	$115,369	$125,276	19
J1747	SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION	$127,833	$108,658	$27,382	$144,732	32
J2327	RISANKIZUMAB-RZAA 150 MG/ML SUBCUTANEOUS SYRINGE	$108,000	$91,800	$97,470	$105,840	19
J2327	RISANKIZUMAB-RZAA 150 MG/ML SUBCUTANEOUS SYRINGE	$108,000	$91,800	$23,134	$122,278	32
J2350	OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION	$98,572	$83,786	$88,961	$96,600	19
J2350	OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION	$98,572	$83,786	$21,114	$111,603	32
J9309	POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION	$90,347	$76,795	$81,538	$88,540	19
J9309	POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION	$90,347	$76,795	$19,352	$102,290	32
J0638	CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION	$85,619	$72,776	$77,271	$83,906	19
J0638	CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION	$85,619	$72,776	$18,340	$96,937	32
J9334	EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11200 UNIT/5.6 ML SUBCUT SOLN	$78,865	$67,035	$71,176	$77,288	19
J9334	EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11200 UNIT/5.6 ML SUBCUT SOLN	$78,865	$67,035	$16,893	$89,291	32
J3241	TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION	$77,358	$65,754	$69,816	$75,811	19
J3241	TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION	$77,358	$65,754	$16,570	$87,585	32
J2507	PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION	$76,930	$65,391	$69,429	$75,391	19
J2507	PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION	$76,930	$65,391	$16,478	$87,100	32
J9298	NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION	$72,662	$61,763	$65,578	$71,209	19
J9298	NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION	$72,662	$61,763	$15,564	$82,268	32
J1628	GUSELKUMAB 200 MG/2 ML SUBCUTANEOUS SYRINGE	$70,283	$59,741	$63,430	$68,877	19
J1628	GUSELKUMAB 200 MG/2 ML SUBCUTANEOUS SYRINGE	$70,283	$59,741	$15,055	$79,574	32
J3245	TILDRAKIZUMAB-ASMN 100 MG/ML SUBCUTANEOUS SYRINGE	$66,589	$56,601	$60,097	$65,257	19
J3245	TILDRAKIZUMAB-ASMN 100 MG/ML SUBCUTANEOUS SYRINGE	$66,589	$56,601	$14,263	$75,392	32
J3357	USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SOLUTION	$60,477	$51,406	$54,581	$59,268	19
J3357	USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SOLUTION	$60,477	$51,406	$12,954	$68,472	32
J9042	BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION	$58,710	$49,904	$52,986	$57,536	19
J9042	BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION	$58,710	$49,904	$12,576	$66,471	32
J9272	DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION	$56,682	$48,180	$51,155	$55,548	19
J9272	DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION	$56,682	$48,180	$12,141	$64,175	32
J9043	CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION	$56,456	$47,988	$50,952	$55,327	19
J9043	CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION	$56,456	$47,988	$12,093	$63,920	32
J9022	ATEZOLIZUMAB 1200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION	$56,259	$47,820	$50,774	$55,134	19
J9022	ATEZOLIZUMAB 1200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION	$56,259	$47,820	$12,051	$63,697	32
J1640	HEMIN 350 MG INTRAVENOUS POWDER FOR SOLUTION	$54,702	$46,497	$49,369	$53,608	19
J1640	HEMIN 350 MG INTRAVENOUS POWDER FOR SOLUTION	$54,702	$46,497	$11,717	$61,934	32
J9144	DARATUMUMAB 1800 MG-HYALURONIDASE-FIHJ 30000 UNIT/15 ML SUBCUT SOLN	$52,595	$44,706	$47,467	$51,543	19
J9144	DARATUMUMAB 1800 MG-HYALURONIDASE-FIHJ 30000 UNIT/15 ML SUBCUT SOLN	$52,595	$44,706	$11,266	$59,548	32
J2329	UBLITUXIMAB-XIIY 25 MG/ML INTRAVENOUS SOLUTION	$52,363	$44,508	$47,257	$51,315	19
J2329	UBLITUXIMAB-XIIY 25 MG/ML INTRAVENOUS SOLUTION	$52,363	$44,508	$11,216	$59,285	32

Showing top 50 of 11,018 priced procedures, sorted by gross charge.

Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.